Application 220375
- Type
- ANDA
- Sponsor
- TORRENT PHARMACEUTICALS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | RUXOLITINIB | RUXOLITINIB | TABLET | 20MG | No | No |
| 003 | RUXOLITINIB | RUXOLITINIB | TABLET | 15MG | No | No |
| 004 | RUXOLITINIB | RUXOLITINIB | TABLET | 10MG | No | No |
| 005 | RUXOLITINIB | RUXOLITINIB | TABLET | 5MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| JAKAFI | RUXOLITINIB | Incyte Corporation | f1c82580-87ae-11e0-bc84-0002a5d5c51b | 2026-07-20 | Warnings, Adverse reactions | RUXOLITINIB |
| OPZELURA | RUXOLITINIB | Incyte Corporation | 24da5509-6631-4795-9d42-273faecd08e7 | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | RUXOLITINIB |